Theron, A., Roth, R. L., Hoppe, H., Parkinson, C., van der Westhuyzen, C. W., Stoychev, S., . . . Kenyon, C. P. (2017). Differential inhibition of adenylylated and deadenylylated forms of M. tuberculosis glutamine synthetase as a drug discovery platform. PLoS ONE, 12(10), 1. https://doi.org/10.1371/journal.pone.0185068
Chicago Style (17th ed.) CitationTheron, A., et al. "Differential Inhibition of Adenylylated and Deadenylylated Forms of M. Tuberculosis Glutamine Synthetase as a Drug Discovery Platform." PLoS ONE 12, no. 10 (2017): 1. https://doi.org/10.1371/journal.pone.0185068.
MLA (9th ed.) CitationTheron, A., et al. "Differential Inhibition of Adenylylated and Deadenylylated Forms of M. Tuberculosis Glutamine Synthetase as a Drug Discovery Platform." PLoS ONE, vol. 12, no. 10, 2017, p. 1, https://doi.org/10.1371/journal.pone.0185068.